Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
NCT01803451
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Post-bariatric Surgery
Interventions
DRUG:
exendin-(9-39)
DRUG:
exendin -(9-39)
Sponsor
The University of Texas Health Science Center at San Antonio